Clinical Trial

A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)

Study acronym: MIDSECTION
Recruiting
View on ClinicalTrials.gov →
Summary
To determine if the investigators are able to deliver highly focused, intense radiation to tumours in the abdominal region or chest cavity whilst limiting the dose to surrounding organs using a high field strength MR-Linac.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-06; most recent amendment 2025-08-29.
Status change: Not Yet Recruiting → Recruiting 2025-08-29
Trial Details
NCT Number NCT05903430
Lead Sponsor The Christie NHS Foundation Trust
Conditions Abdominal Cancer, Lung Cancer
Enrollment 60 participants
Start Date 2025-08-29
Primary Completion 2027-01-29 (estimated)
Study Completion 2027-01-29 (estimated)
Updated on ClinicalTrials.gov 2025-09-05